Equities

Treace Medical Concepts Inc

TMCI:NSQ

Treace Medical Concepts Inc

Actions
  • Price (USD)7.94
  • Today's Change-0.04 / -0.50%
  • Shares traded309.62k
  • 1 Year change-6.59%
  • Beta0.4955
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments12381106
Total Receivables, Net382919
Total Inventory291911
Prepaid expenses7.853.623.01
Other current assets, total------
Total current assets198133138
Property, plant & equipment, net32252.85
Goodwill, net13----
Intangibles, net9.03----
Long term investments------
Note receivable - long term------
Other long term assets0.150.15--
Total assets252159141
LIABILITIES
Accounts payable128.674.06
Accrued expenses302214
Notes payable/short-term debt000
Current portion long-term debt/capital leases------
Other current liabilities, total3.03----
Total current liabilities453018
Total long term debt535329
Total debt535329
Deferred income tax------
Minority interest------
Other liabilities, total16160.17
Total liabilities1149848
SHAREHOLDERS EQUITY
Common stock0.060.060.05
Additional paid-in capital272145135
Retained earnings (accumulated deficit)(134)(85)(42)
Treasury stock - common(0.01)----
Unrealized gain (loss)------
Other equity, total0.16(0.03)--
Total equity1386193
Total liabilities & shareholders' equity252159141
Total common shares outstanding625654
Treasury shares - common primary issue0.0000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.